Kezar Life Sciences's total assets for Q3 2025 were $97.73M, a decrease of -10.44% from the previous quarter. KZR total liabilities were $14.75M for the fiscal quarter, a -14.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.